INTRODUCTION {#s1}
============

Colorectal cancer is the most-common malignant tumor worldwide, with over 132,700 new cases and 49,700 deaths estimated every year in the United State \[[@R1]\]. Epidemiological data reported by the International Agency for Research on Cancer (IARC) demonstrated that colorectal cancer accounts for 8.3% and 6.3% of all malignancies incidence and mortality in China, respectively \[[@R2]\]. The occurrence and development of colorectal cancer is caused by a series of multifactorial and complex factors including environmental alterations and genetic aspects \[[@R3], [@R4]\]. In recent years, considerable genome-wide association studies (GWAS) have identified numerous genetic variants impacting the risk of colorectal cancer \[[@R5]--[@R8]\]. Zhang *et al*. conducted a GWAS in East Asians and identified 6 new loci associated with colorectal cancer risk \[[@R9]\]. In addition, Jia *et al*. identified three new colorectal cancer susceptibility loci \[[@R10]\]. These studies provide additional insights into the genetic and biological basis of colorectal cancer.

As we known, the abnormality of gene expression may increase the risk or severity of diseases \[[@R11]--[@R13]\]. Long noncoding RNAs (lncRNAs) have also been implicated in the crucial functions of various biological process involved in cancer susceptibility \[[@R14], [@R15]\]. The lncRNA *H19*, highly conserved on chromosome 11p15.5 in human, is a maternal expressed gene that plays key roles in embryogenesis during fetal time \[[@R16], [@R17]\]. However, it is down-expressed in maturing tissues postnatal \[[@R18]\]. Accumulating evidences suggested that *H19* was up-regulated in a variety of cancer types, including breast cancer \[[@R19], [@R20]\], esophageal cancer \[[@R21]\], bladder cancer \[[@R22]\] and colorectal cancer \[[@R23]\]. In addition, the differentially methylated regions (DMRs), which located upstream of the transcription start of *H19*, act the part of methylation-sensitive insulator \[[@R24]\]. Furthermore, emerging studies indicated that *H1*9 may activate tumorigenicity by acting as the precursors of microRNAs (miRNAs) or competitive endogenous RNAs (ceRNAs) \[[@R25]--[@R27]\]. Tsang *et al*. observed that miR-675, derived from *H19*, may decrease the expression of retinoblastoma (*RB*) and increase the growth and development of colorectal cancer cells \[[@R28]\]. Induction of epithelial-mesenchymal transition (EMT) in cancer cells due to aberrant *H19* expression can promote pancreatic ductal adenocarcinoma cell invasion and migration \[[@R29]\].

Recently several single nucleotide polymorphisms (SNPs) within lncRNA genes have been extensively confirmed to modulate the expression and function of lncRNA and further cause tumor susceptibility and prognosis changing \[[@R30], [@R31]\]. As for SNPs in lncRNA *H19*, cumulative studies have identified the associated with malignant diseases \[[@R32], [@R33]\]. In this study, we conducted a case-control study to genotype the candidate SNPs in *H19* (rs2839698, rs3024270, rs217727, and rs2735971) and investigate the association with the risk of colorectal cancer.

RESULTS {#s2}
=======

Characteristics of the study subjects {#s2_1}
-------------------------------------

1147 colorectal cancer patients and 1203 controls were recruited in this study. No significant differences were observed regarding to age and gender between patients and cancer-free controls (*P* = 0.751 and *P* = 0.116, respectively), indicating satisfactory matching by these factors. There were no significant differences in smoking and drinking status between the patients and controls (*P* \> 0.05). However, more colorectal cancer individuals were found to have family history of cancers than subjects in control (*P* \< 0.001). For tumor grade, 7.4% of colorectal cancer cases were in low grade, and 76.7% in the intermediate, and 15.9% in the high grade. Moreover, the frequencies of the tumor Duke\'s stage were 8.4% (A), 43.1% (B), 36.8% (C) and 11.7% (D).

Associations of selected SNPs in *H19* and colorectal cancer risk {#s2_2}
-----------------------------------------------------------------

The positions of four selected SNPs in *H19* are shown in Figure [1](#F1){ref-type="fig"}. Primary information and the distributions of genotypes were consistent with those expected from Hardy-Weinberg equilibrium (HWE) in the control group (*P* = 0.666 for rs2839698, *P* = 0.979 for rs3024270, *P* = 0.959 for rs217727 and *P* = 0.175 for rs2735971, respectively. Besides, we calculated genotype frequencies of *H19* tagSNPs among cases and controls and their associations with colorectal cancer risk according to variant genetic effect models (additive, dominant, recessive and co-dominant models) (Table [1](#T1){ref-type="table"}, [Supplementary Table S1](#SD1){ref-type="supplementary-material"}). As a result, we observed that rs2839698 was significantly associated with the risk of colorectal cancer after the adjustment for age, gender, smoking and drinking status by performing multivariate logistic regression analysis in additive model \[odds ratios (ORs) = 1.20, 95% confidence intervals (CIs) = 1.05--1.36, *P* = 0.007 and *P* = 0.028 after Bonferroni correction\]. No significant association between rs3024270, rs217727 and rs2735971 and colorectal cancer risk were found in the additive model.

![Selected tagSNPs and relative position in *H19*\
E1, E2, E3, E4, E5 and DMR indicates exon 1, exon 2, exon 3, exon 4, exon 5, and differentially methylated regions, respectively, whereas the line indicates the introns.](oncotarget-07-25470-g001){#F1}

###### Associaiton between the selected tagSNPs and the risk of colorectal cancer

  SNPs        Location[^a^](#tfn_001){ref-type="table-fn"}   Position         Alleles[^b^](#tfn_002){ref-type="table-fn"}   Cases[^c^](#tfn_003){ref-type="table-fn"}(n = 1147)   Controls[^c^](#tfn_004){ref-type="table-fn"}(n = 1203)   MAF[^d^](#tfn_005){ref-type="table-fn"}(Case/control)   *P*~HWE~^e^   Adjusted OR (95% CI)[^f^](#tfn_006){ref-type="table-fn"}   *P*[^h^](#tfn_008){ref-type="table-fn"}   *P*[^i^](#tfn_009){ref-type="table-fn"}                                                     
  ----------- ---------------------------------------------- ---------------- --------------------------------------------- ----------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------- ------------- ---------------------------------------------------------- ----------------------------------------- ----------------------------------------- ------------------ ---------------------- ------- -------
  rs2839698   2018853                                        Exon1            G/A                                           583/462/102                                           666/462/75                                               0.290/0.254                                             0.666         **1.20 (1.05-1.36)**                                       **1.20 (1.02-1.41)**                      **1.46 (1.07-1.99)**                      1.14 (0.96-1.35)   **1.54 (1.12-2.12)**   0.007   0.028
  rs3024270   2017439                                        Intron           C/G                                           385/527/235                                           420/582/201                                              0.435/0.409                                             0.979         1.11 (0.99-1.24)                                           1.06 (0.90-1.26)                          **1.29 (1.04-1.58)**                      0.99 (0.83-1.19)   **1.28 (1.01-1.61)**   0.079   0.316
  rs217727    2016908                                        Exon5            G/A                                           480/514/153                                           456/570/177                                              0.357/0.334                                             0.959         0.89 (0.79-1.00)                                           0.84 (0.71-1.00)                          0.89 (0.71-1.13)                          0.85 (0.71-1.01)   0.82 (0.64-1.06)       0.056   0.224
  rs2735971   2021649                                        Promoter (DMR)   T/C                                           773/334/40                                            765/398/40                                               0.180/0.199                                             0.175         0.89 (0.77-1.03)                                           0.85 (0.72-1.01)                          1.06 (0.68-1.66)                          0.83 (0.70-1.00)   1.00 (0.64-1.57)       0.125   0.500

Abbreviations: OR, odds ratio; Cl, confidence interval.

Location in GRCh 37.

Major/minor.

Numbers of major homozygote/heterozygote/minor homozygote.

Minor allele frequency in cases/controls.

HWE, Hardy-Weinberg equilibrium in control subjects.

Adjusted for age, sex, smoking and drinking status in logistic regression model.

het: heterozygote versus major homozygote; hom: minor homozygote versus major homozygote.

*P* for additive model.

*P* after Bonferroni correction.

Stratification analysis of associations between rs2839698 and colorectal cancer {#s2_3}
-------------------------------------------------------------------------------

To exclude whether the possible confounders play roles in the colorectal cancer risk, we conducted the stratified analysis upon the associations between rs2839698 and colorectal cancer by age, sex, smokers, drinkers and family history of cancers. Due to the small number of AA genotype group, we performed the stratification analysis under dominant model. As shown in Table [2](#T2){ref-type="table"}, more profoundly increased risk of colorectal cancer were identified in terms of younger subjects (age ≤ 61) (*P* = 0.007), males (*P* = 0.022), drinkers (*P* = 0.008) and smokers (*P* = 0.002).

###### Stratification analyses for rs2839698 genotypes and colorectal cancer risk

  Variables         Genotypes for rs2839698 (cases/controls)   Adjusted OR (95% CI)   *P*[a](#tfn_010){ref-type="table-fn"}                                      
  ----------------- ------------------------------------------ ---------------------- --------------------------------------- ----------- ---------------------- -------
  Age (years)                                                                                                                                                    
   ≤ 61             303/251                                    50.2/42.7              300/337                                 49.8/57.3   **1.39 (1.10-1.76)**   0.007
   \> 61            261/286                                    48.0/46.5              283/329                                 52.0/53.5   1.07 (0.84-1.37)       0.560
  Sex                                                                                                                                                            
   Male             349/306                                    49.7/43.8              353/392                                 50.3/56.2   **1.29 (1.04-1.61)**   0.022
   Female           215/231                                    48.3/45.7              230/274                                 51.7/54.3   1.15 (0.88-1.50)       0.296
  Smoking status                                                                                                                                                 
   Never            344/369                                    46.8/45.5              392/442                                 53.3/54.5   1.05 (0.86-1.29)       0.635
   Ever             220/168                                    53.5/42.9              191/224                                 46.5/57.1   **1.57 (1.18-2.10)**   0.002
  Drinking status                                                                                                                                                
   Never            393/408                                    47.8/45.4              430/490                                 52.2/54.6   1.11 (0.92-1.35)       0.276
   Ever             171/129                                    52.8/42.3              153/176                                 47.2/57.7   **1.58 (1.13-2.20)**   0.008
  FH                                                                                                                                                             
   No               444/477                                    49.1/44.3              460/599                                 50.9/55.7   **1.21 (1.01-1.45)**   0.042
   Yes              120/60                                     49.4/47.2              123/67                                  50.6/52.8   1.20 (0.77-1.89)       0.422

Adjusted for age, sex, smoking and drinking status in logistic regression models.

Abbreviations: OR, odds ratio; CI, confidence interval; FH, family history of cancers.

Association between rs2839698 and clinicopathologic characteristics of colorectal cancer {#s2_4}
----------------------------------------------------------------------------------------

Next, we performed the subgroup analysis in different clinicopathologic variables to evaluate the relationship between rs2839698 and colorectal cancer risk. As shown in [Supplementary Table S2](#SD1){ref-type="supplementary-material"}, rs2839698 GA/AA genotypes were associated with an increased risk of colorectal cancer in individuals with colon tumor site (OR = 1.25, 95% CI = 1.02--1.52, *P* = 0.033), well differentiated grade (OR = 1.54, 95% CI = 1.13--2.11, *P* = 0.007) and Duke\'s C/D stage (OR = 1.37 95% CI = 1.12--1.68, *P* = 0.002). However, no dramatically significant risk effect of colorectal cancer was observed in other subgroups.

Prediction of rs2839698 on *H19* folding structures and target miRNAs {#s2_5}
---------------------------------------------------------------------

We performed *in silico* analyses using RNAfold and SNPfold to predict the *H19* secondary structure of selected SNPs. As a result, the secondary structure was dramatically changed with rs2839698 G/A alleles (Figure [2](#F2){ref-type="fig"}), rs3024270 C/G alleles and rs217727 G/A alleles ([Supplementary Figure S1](#SD1){ref-type="supplementary-material"}). However, there were few changes with rs2735971 T/C alleles.

![Bioinformatics prediction of rs2839698 on *H19* folding structure\
The folding structure alterations were demonstrated by RNAfold (**A**) and SNPfold (**B**), respectively. Arrow (A) indicates the change in structure caused by rs2839698. Arrow a indicates the position of rs2839698. Arrow G indicates the sequences of G allele, whereas arrow A indicates the A allele.](oncotarget-07-25470-g002){#F2}

According to the fact that rs2839698 (G/A) is located in the exon (3′untranslated region) of *H19* gene, we speculate that genetic variant in rs2839698 may change the promoter activity and function of *H19* to a certain extent through alteration of target miRNAs and subsequently lead to colorectal cancer. Consequently, we used miRNASNP v2.0 to predict whether rs2839689 (G/A) in 3′untranslated region of *H19* gene can induce target miRNAs gain/loss. We found that hsa-miR-24--1--5p, hsa-miR-4486, hsa-miR-566 and hsa-miR-24--2--5p may lose the target *H19* gene, following with the creating binding site of hsa-miR-612, hsa-miR-5189, hsa-miR-1285--3p and hsa-miR-3187--5p ([Supplementary Table S3](#SD1){ref-type="supplementary-material"}).

DISCUSSION {#s3}
==========

*H*19 is a paternally imprinted oncofetal lncRNA gene locus on chromosome 11p15.5 which is down-regulated after birth and possesses oncogenic properties. Previous studies have indicated that *H19* involves in the complex biological process of oncogenesis \[[@R26], [@R34], [@R35]\]. Liang *et al*. reported that the lncRNA *H19* play the part of miRNA sponges to promoting EMT in colorectal cancer \[[@R36]\]. *H19* may also act as a primary miRNA precursor to continue the function \[[@R37]\]. Moreover, *H19* has the potential to produce *91H* RNA, which regulates insulin like growth factor 2 (*IGF2*) expression and is over-expressed in breast cancer cells \[[@R38]\]. Despite of extensive evidence, the function of *H19* in the molecular mechanism of tumorigenesis is still not clear. Emerging evidences have implied that genetic variants in lncRNAs may modify the risk of multiply tumors \[[@R30], [@R39]\]. Verhaegh *et al*. have found that *H19* gene polymorphisms were concerned in susceptibility of bladder cancer in European Caucasians \[[@R33]\]. However, to our knowledge, no data previously has explored the correlation between *H19* genetic variants and colorectal cancer susceptibility in a Chinese population.

In this study, we selected four tagSNPs (rs2839698, rs3024270, rs217727, and rs2735971) in *H19* gene and DMR to estimate the association between these variants and colorectal cancer susceptibility. We observed that rs2839698 GA/AA genotype has an increased risk of colorectal cancer in the Chinese populations compared with the GG genotype. Yang *et al*. also demonstrated that rs2839698 contributed to the risk of gastric cancer in a Chinese population \[[@R32]\]. All of the above suggested that *H19* genetic variants play an important role in cancer susceptibility.

Some environmental factors, such as alcohol intake and tobacco smoking, were related with the elevated colorectal cancer risk \[[@R40]--[@R42]\]. Our stratified analyses demonstrated that individuals, including smokers and drinkers, carrying rs2839698 GA/AA genotype had a significantly increased susceptibility of colorectal cancer. Therefore, the markedly induced risk of colorectal cancer associated with variant rs2839698 genotypes could partly attribute to the accumulated exposure/exposure history to alcohol consumption or tobacco carcinogens. Moreover, we found that increased colorectal cancer risk correlated with rs2839698 was more remarkable in subgroups of younger individuals and male, suggested that promoting effects of *H19* variants on colorectal cancer may be modulated by specific epidemiological features. These results provided confirmed that colorectal cancer tumorigenesis is a complex and multistep process involving diverse genetic and environmental modifications. However, we found that the associations of colorectal cancer risk in subjects with and without family history of cancers were almost the same. It is reasonable that the number of controls with family history was less than the patients.

We further found that rs2839698 GA/AA genotype had an increased risk of colorectal cancer among patients with Duke\'s stage of C or D. It is rational that the genetic variants may play a vital role in the advanced stage of colorectal cancer and lead to our present result. However, the results showed that subjects with the gene loci variation were involved in the obviously increased risk of colorectal cancer among colon site and well differentiated grade subgroups, indicating that different colorectal cancer site and grade regulated by different molecular biological mechanisms may bring about different level of risk in carcinogenesis of colorectal cancer \[[@R43]\].

Given the important function influence of folding structure changes of lncRNAs caused by SNPs, we predicted the secondary structure changes of *H19* ascribed to selected SNPs using RNAfold and SNPfold algorithms. We found that the folding architectures markedly changed along with the genetic variant of rs2839689, rs3024270, rs217727, and rs2735971, suggested that SNPs may be involved in occurrence and development of colorectal cancer by altering the specific structural motifs of *H19* and exerting various effects on *H19* expression and function \[[@R44]\]. Besides, accumulating studies have revealed that SNPs in lncRNAs can be directly regulated and modified by miRNAs \[[@R34], [@R43]\], and SNPs might be plausible reason for alteration of interactions between miRNAs and lncRNAs \[[@R45]\]. Based on previous evidence, miRNASNP v2.0 was used to predict the lost miRNAs of wild sequence and the obtained miRNAs of SNP sequence. We found that four obtained miRNAs and four lost miRNAs possibly linked with lncRNA *H19*. The changes of target miRNAs may potentially affect the expression and function of *H19* due to rs2839689 variant, which ultimately modulate the risk of colorectal cancer.

In summary, we have provided the evidence that *H19* rs2839689 contributes to the susceptible to colorectal cancer in the Chinese population. Further both larger prospective studies and functional researches are needed to validate the finding in different ethnicities.

MATERIALS AND METHODS {#s4}
=====================

Study participants {#s4_1}
------------------

The present study was approved by the Institutional Review Board of Nanjing Medical University. All the study participants were genetically unrelated Chinese and provided written informed consent. Briefly we consecutively recruited 1,147 patients with colorectal cancer and 1,203 cancer-free controls. All cases were histopathologically confirmed colorectal tumor from the Affiliated Nanjing First Hospital and the First Affiliated Hospital of Nanjing Medical University on September 2010, without age or sex restrictions. Control individuals were matched to the cases based upon age (± 5 years) and sex. Details of the study participants have been demonstrated previously \[[@R39], [@R46]\].

SNP selection {#s4_2}
-------------

We focused on both lncRNA *H19* gene and its promoter (including DMR) located in human chromosome 11p15.5 using UCSC browser (<http://genome.ucsc.edu/>). Four SNPs were selected on the basis of four filtering criteria: (a) minor allele frequency (MAF) \> 0.05 in the CHB and JPT population from the 1000 Genomes Project; (b) *r*^2^ \> 0.8 analyzed based on pairwise linkage disequilibrium using Haploview version 4.0; (c) the secondary structure changed using RNAfold; (d) the Gibbs binding free energy (ΔG, kJ/mol) \> 0.

Genotyping {#s4_3}
----------

Genotyping was performed using the TaqMan allelic discrimination assay. The 384-well ABI 7900HT real-time PCR system (Applied Biosystems, Foster City, CA, USA) was applied to amplify all the sample genotypes, with SDS 2.4 software (Applied Biosystems) used to read and analyze allelic discrimination. Both the sequences of the primers and fluorescent probes are showed in [Supplementary Table S4](#SD1){ref-type="supplementary-material"}. The average call rates for four SNPs were more than 99%. Additionally, we randomly selected over 10% of the samples for repeated assays and the final concordance rate between duplicate samples was 100%.

*In silico* prediction of secondary structures and target miRNAs {#s4_4}
----------------------------------------------------------------

We used RNAfold (<http://rna.tbi.univie.ac.at/>) \[[@R47]\] and SNPfold (<http://ribosnitch.bio.unc.edu/snpfold/SNPfold.html>) \[[@R44]\] algorithms to predict the folding structure variants of *H19* on account of tagSNPs genotypes. In addition, miRNASNP v2.0 (<http://bioinfo.life.hust.edu.cn/miRNASNP2/>) was used to predict the target miRNAs of *H19*.

Statistical analysis {#s4_5}
--------------------

Differences in the distribution of epidemiological variables between cases and controls were calculated using Student\'s *t*-tests (continuous variables) and chi-square χ^2^ tests (categorical variables). The crude and adjusted ORs and 95% CIs were using to examine the correlation between different genotypes and colorectal cancer risk from unconditional univariate as well as multivariate logistic regression analyses under variant genetic models. Age, sex and smoking and drinking status were involved in the possible confounders in order to perform multivariate logistic regression analyses. HWE in the cancer-free groups was computed by a goodness-of fit chi-square test. Linkage equilibrium (LD) between SNPs in *H19* was calculated using Haploview 4.0 software. Bonferroni correction was applied to conservatively account for multiple comparisons. All outputted *P*-values were 2-sided and the criterion of *P*-value for statistical significance is less than 0.05. Moreover, all of the tests were performed using SAS software package (version 9.1.3; SAS Institute, Inc., Cary, NC).
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